RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Jointown Pharmaceutical Group Co Stock

Jointown Pharmaceutical Group Co P/S 2024

Jointown Pharmaceutical Group Co P/S

0.18

Ticker

600998.SS

ISIN

CNE100000W45

As of Sep 29, 2024, Jointown Pharmaceutical Group Co's P/S ratio stood at 0.18, a -10% change from the 0.2 P/S ratio recorded in the previous year.

The Jointown Pharmaceutical Group Co P/S history

Jointown Pharmaceutical Group Co Aktienanalyse

What does Jointown Pharmaceutical Group Co do?

Jointown Pharmaceutical Group Co Ltd is a Chinese company specializing in the production and distribution of pharmaceuticals. The company was founded in 1999 in Wuhan and has since become a significant player in the pharmaceutical industry. The company's business model is based on the production and sale of generic drugs, which are cheaper alternatives to existing medications. This makes them more affordable for many people. Jointown Pharmaceuticals operates in various areas, with one of the main areas being the production of cancer drugs. The company manufactures a variety of cancer medications and is one of the leading manufacturers in China in this field. Jointown Pharmaceuticals is also active in other areas of medicine, such as producing medications for diabetes, infectious diseases, and cardiovascular diseases. The company offers a wide range of products, including generics, patented medications, medical devices, diagnostics, dietary supplements, and cosmetic products. Jointown Pharmaceuticals emphasizes close collaboration with scientific institutions and partnerships with foreign partners in order to drive the development of new products and expand internationally. Jointown is also active in Germany through its subsidiary, Jointown Europe GmbH. The company's history is marked by steady growth. Jointown Pharmaceuticals has become one of the leading pharmaceutical companies in China within a few years and has gained international recognition. In 2013, the company successfully went public, generating additional financial resources. In addition to its pharmaceutical business, Jointown Pharmaceuticals is also involved in social projects. The company contributes to the fight against poverty and diseases in China and prioritizes environmental protection and sustainability. Overall, Jointown Pharmaceuticals is an innovative and successful company in the pharmaceutical industry. Its focus on the production of generics contributes significantly to providing affordable medications to the population. The wide range of products and the close collaboration with international partners demonstrate a modern and globally oriented corporate culture. Jointown Pharmaceutical Group Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Jointown Pharmaceutical Group Co's P/S Ratio

Jointown Pharmaceutical Group Co's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Jointown Pharmaceutical Group Co's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Jointown Pharmaceutical Group Co's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Jointown Pharmaceutical Group Co’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Jointown Pharmaceutical Group Co stock

What is the price-to-earnings ratio of Jointown Pharmaceutical Group Co?

The price-earnings ratio of Jointown Pharmaceutical Group Co is currently 0.18.

How has the price-earnings ratio of Jointown Pharmaceutical Group Co changed compared to last year?

The price-to-earnings ratio of Jointown Pharmaceutical Group Co has increased by -10% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Jointown Pharmaceutical Group Co high compared to other companies?

Yes, the price-to-earnings ratio of Jointown Pharmaceutical Group Co is high compared to other companies.

How does an increase in the price-earnings ratio of Jointown Pharmaceutical Group Co affect the company?

An increase in the price-earnings ratio of Jointown Pharmaceutical Group Co would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Jointown Pharmaceutical Group Co affect the company?

A decrease in the price-earnings ratio of Jointown Pharmaceutical Group Co would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Jointown Pharmaceutical Group Co?

Some factors that influence the price-earnings ratio of Jointown Pharmaceutical Group Co are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Jointown Pharmaceutical Group Co pay?

Over the past 12 months, Jointown Pharmaceutical Group Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Jointown Pharmaceutical Group Co is expected to pay a dividend of 0.24 CNY.

What is the dividend yield of Jointown Pharmaceutical Group Co?

The current dividend yield of Jointown Pharmaceutical Group Co is .

When does Jointown Pharmaceutical Group Co pay dividends?

Jointown Pharmaceutical Group Co pays a quarterly dividend. This is distributed in the months of July, July, July, July.

How secure is the dividend of Jointown Pharmaceutical Group Co?

Jointown Pharmaceutical Group Co paid dividends every year for the past 6 years.

What is the dividend of Jointown Pharmaceutical Group Co?

For the upcoming 12 months, dividends amounting to 0.24 CNY are expected. This corresponds to a dividend yield of 4.64 %.

In which sector is Jointown Pharmaceutical Group Co located?

Jointown Pharmaceutical Group Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Jointown Pharmaceutical Group Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Jointown Pharmaceutical Group Co from 6/7/2024 amounting to 0.194 CNY, you needed to have the stock in your portfolio before the ex-date on 6/7/2024.

When did Jointown Pharmaceutical Group Co pay the last dividend?

The last dividend was paid out on 6/7/2024.

What was the dividend of Jointown Pharmaceutical Group Co in the year 2023?

In the year 2023, Jointown Pharmaceutical Group Co distributed 0.3 CNY as dividends.

In which currency does Jointown Pharmaceutical Group Co pay out the dividend?

The dividends of Jointown Pharmaceutical Group Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Jointown Pharmaceutical Group Co

Our stock analysis for Jointown Pharmaceutical Group Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Jointown Pharmaceutical Group Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.